Epigenetic Reprogramming Agent (Phase 1 trial)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Epigenetic Reprogramming Agent (Phase 1 trial), covering 2019-01-24 to 2019-01-24. Get the full timeline:
Most recent: Clinical Trial Update: Epigenetic Reprogramming in Relapse AML [Phase 1]